Menu Back toRound Table Discussion: Implicit Bias in Early Phase Clinical Trials: The Sociocultural Implications of Advancing the Science

DIA 2021 Global Annual Meeting


Round Table Discussion: Implicit Bias in Early Phase Clinical Trials: The Sociocultural Implications of Advancing the Science

Session Chair(s)

Mary  Murray, MBA, MS

Mary Murray, MBA, MS

  • Vice President, Collaborative Action Networks
  • National Minority Quality Forum, United States
Join DIA Patient Engagement Community for a round table discussion tied to session #116 SL Implicit Bias in Early Phase Clinical Trials: The Sociocultural Implications of Advancing the Science scheduled for Monday, June 28 1-2 PM EDT. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.

Speaker(s)

Lovingly  Park, PhD

Lovingly Park, PhD

  • Director, Clinical Research
  • Supernus Pharmaceurticaals, Inc., United States
Lucas  Kempf, MD

Lucas Kempf, MD

  • Vice President, RCS
  • Parexel, United States
Mandi L. Pratt-Chapman, PhD

Mandi L. Pratt-Chapman, PhD

  • Associate Center Director, Patient Centered Initiatives & Health Equity
  • The GW Cancer Center, United States